-
BP8 Sources Bird’s Nest Products from Chinese State-Owned Conglomerate China National Pharmaceutical Group Corporation (Commonly Known as Sinopharm)
06 Jun 2024 04:43 GMT
… concomitant medications, including prescription medicines, over-the-counter drugs, vitamins … several randomized clinical trials were conducted to … to establish the biotechnology industry and remains … trial of amrubicin versus topotecan as second-line treatment …
-
Analysis of Clinical Trials Using Anti-Tumor Traditional Chinese Medicine Monomers
05 Jun 2024 09:42 GMT
… -making references for pharmaceutical researchers, enterprises, institutions … addition, trials in this investigation involved CRLX101 (5), topotecan ( … drug. CRLX101 was identified in a clinical trial on the treatment … anti-cancer agents. Biotechnol Adv. 2018;36 …
-
Human medicines European public assessment report (EPAR): Avzivi, bevacizumab, Status: Opinion
31 May 2024 14:36 GMT
… for the medicinal product Avzivi, intended for the treatment of carcinoma … paclitaxel, topotecan, or pegylated liposomal doxorubicin is indicated for the treatment of … in the use of antineoplastic medicinal products.
Detailed recommendations for the …
-
EMA Panel Nods to Seven New Cancer Drugs
31 May 2024 18:58 GMT
… CHMP) of the European Medicines Agency (EMA) endorsed … Pharmaceuticals Deutschland GmbH), intended for the first-line treatment … from the GEMSTONE-302 trial, which demonstrated significant … , topotecan, or pegylated liposomal doxorubicin for the treatment of …
-
Pediatric rare disease drug Qarziba gets green light for coverage
30 May 2024 04:43 GMT
… received feedback from medical associations, including the Korean Medical Association and … drugs, activities, and treatment materials.
As a result, in gynecologic cancers, topotecan … Lutathera was limited to six treatments (four covered and two uncovered …
-
Verastem Oncology begins rolling submission of NDA to US FDA seeking accelerated approval of avutometinib & defactinib combination to treat recurrent KRAS mutant LGSOC
28 May 2024 12:08 GMT
… to advancing new medicines for patients with cancer … Orphan Drug Designation by the FDA for the treatment of … (pegylated liposomal doxorubicin, paclitaxel, topotecan) or hormone therapy (letrozole … and RAMP 204 (NCT05375994) trials, respectively. The RAMP 205 …
-
Verastem Oncology Announces the Initiation of a Rolling Submission of NDA to FDA Seeking Accelerated Approval of Avutometinib and Defactinib Combination for the Treatment of Adult Patients with Recurrent KRAS Mutant Low-Grade Serous Ovarian Cancer
24 May 2024 11:11 GMT
… Orphan Drug Designation by the FDA for the treatment of … (pegylated liposomal doxorubicin, paclitaxel, topotecan) or hormone therapy (letrozole … and RAMP 204 (NCT05375994) trials, respectively. The RAMP 205 … that we or Chugai Pharmaceutical Co., Ltd. will …
-
FDA APPROVES IMDELLTRA , THE FIRST AND ONLY T-CELL ENGAGER THERAPY FOR THE TREATMENT OF EXTENSIVE-STAGE SMALL CELL LUNG CANCER
17 May 2024 05:23 GMT
… Drug Administration (FDA) has approved IMDELLTRA™ (tarlatamab-dlle) for the treatment … to establish the biotechnology industry and remains … trial of amrubicin versus topotecan as second-line treatment … 2903.
Clinical Trials. Tarlatamab Clinical Trial Listings. …
-
Pfizer & Genmab's Tivdak receives US FDA full approval to treat recurrent or metastatic cervical cancer
02 May 2024 05:42 GMT
… US Food and Drug Administration (FDA) approves the … FDA to medicines that may offer significant advances in treatment … advances in effective vaccination and screening practices … of single agent chemotherapy (topotecan, vinorelbine, gemcitabine, irinotecan, …
-
FDA Approves Tivdak for Metastatic Cervical Cancer
29 Apr 2024 21:47 GMT
… and Drug Administration (FDA) approved Tivdak (tisotumab vedotin-tftv) for the treatment of … findings from the innovaTV 301 trial, which included 502 patients with … chose from chemotherapy consisting of topotecan, vinorelbine, gemcitabine, irinotecan, or …